Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 3
Submit an article Journal homepage
434
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Dapagliflozin: an emerging treatment option in type 2 diabetes

Mark Kipnes DGD Research Associates, Inc., a Cetero Research Company, 5107 Medical Drive, San Antonio, TX 78229, USA +1 210 614 8612; +1 210 615 1666; [email protected]
Pages 327-334 | Published online: 09 May 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Niki Katsiki, Nikolaos Papanas & Dimitri P Mikhailidis. (2010) Dapagliflozin: more than just another oral glucose-lowering agent?. Expert Opinion on Investigational Drugs 19:12, pages 1581-1589.
Read now
William N Washburn. (2009) Evolution of sodium glucose co-transporter 2 inhibitors as anti-diabetic agents. Expert Opinion on Therapeutic Patents 19:11, pages 1485-1499.
Read now

Articles from other publishers (11)

Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 419 458 .
S. Cangoz, Y.-Y. Chang, S. J. Chempakaseril, R. C. Guduru, L. M. Huynh, J. S. John, S. T. John, M. E. Joseph, R. Judge, R. Kimmey, K. Kudratov, P. J. Lee, I. C. Madhani, P. J. Shim, S. Singh, S. Singh, C. Ruchalski & R. B. Raffa. (2013) The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors. Journal of Clinical Pharmacy and Therapeutics 38:5, pages 350-359.
Crossref
Yoshihito Ohtake, Tsutomu Sato, Takamitsu Kobayashi, Masahiro Nishimoto, Naoki Taka, Koji Takano, Keisuke Yamamoto, Masayuki Ohmori, Marina Yamaguchi, Kyoko Takami, Sang-Yong Yeu, Koo-Hyeon Ahn, Hiroharu Matsuoka, Kazumi Morikawa, Masayuki Suzuki, Hitoshi Hagita, Kazuharu Ozawa, Koji Yamaguchi, Motohiro Kato & Sachiya Ikeda. (2012) Discovery of Tofogliflozin, a Novel C -Arylglucoside with an O -Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes . Journal of Medicinal Chemistry 55:17, pages 7828-7840.
Crossref
Celine Foote, Vlado Perkovic & Bruce Neal. (2012) Effects of SGLT2 inhibitors on cardiovascular outcomes. Diabetes and Vascular Disease Research 9:2, pages 117-123.
Crossref
Raktim Kumar Ghosh, Samhati Mondal Ghosh, Shalini Chawla & Sarfaraz Abdeli Jasdanwala. (2013) SGLT2 Inhibitors: A New Emerging Therapeutic Class in the Treatment of Type 2 Diabetes Mellitus. The Journal of Clinical Pharmacology 52:4, pages 457-463.
Crossref
E. J. Verspohl. (2012) Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes. Pharmacological Reviews 64:2, pages 188-237.
Crossref
Carmen Castaneda-Sceppa & Francisco Castaneda. (2011) Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes. Nutrition Reviews 69:12, pages 720-729.
Crossref
David P. Nickerson, Jonna R. Terkildsen, Kirk L. Hamilton & Peter J. Hunter. (2011) A tool for multi-scale modelling of the renal nephron. Interface Focus 1:3, pages 417-425.
Crossref
Masayuki Isaji. (2011) SGLT2 inhibitors: molecular design and potential differences in effect. Kidney International 79, pages S14-S19.
Crossref
Amit D Raval, Ketan Chovatiya, Ankit B Bhavsar & Megha H Patel. (2011) Dapagliflozin for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2021:12.
Crossref
Anupa K. Patel & Vivian Fonseca. (2010) Turning Glucosuria into a Therapy: Efficacy and Safety with SGLT2 Inhibitors. Current Diabetes Reports 10:2, pages 101-107.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.